CLINICAL_TRIALS
trial_result
· 2013-01-01
Clinical Trial Update: Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria [Phase 2]
Summary
Phase 2 trial evaluating betaine to reduce urine oxalate in patients with Type 1 primary hyperoxaluria. Results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Hyperoxaluria | Phase 2 | Status: COMPLETED | Results posted: 2013-01-01